BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NYSE MKT: TXMD) today announced the pricing of an underwritten public offering of approximately 3.8 million shares of its common stock, offered at a price of $7.80 per share. The gross proceeds to TherapeuticsMD from this offering are expected to be approximately $30.0 million, before deducting underwriting discounts, commissions and other offering expenses payable by TherapeuticsMD. In addition, TherapeuticsMD has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to approximately 577,000 additional shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is expected to close on or about July 15, 2015, subject to the satisfaction of customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.